Medivitan Iv Ampullen (Cyanocobalamin, Folic Acid, Pyridoxine Hydrochloride)

Cyanocobalamin (vitamin B12) serves as a cofactor for enzymes involved in DNA synthesis, red blood cell formation and neurological function. By supplying the active form of B12, it supports normal hematopoiesis, helps maintain nerve health and assists in the metabolism of fatty acids and amino acids.

The dose of Medivitan Iv Ampullen is determined by the prescribing healthcare professional based on the patient’s specific deficiency, weight, age and clinical condition. The prescriber will decide the volume and frequency of injection appropriate for each individual case.

Safety data for Medivitan Iv Ampullen in pregnancy and lactation are limited. Healthcare providers should evaluate the risk‑benefit ratio for each patient. If treatment is deemed necessary, the prescriber will consider the lowest effective dose and monitor both mother and infant closely.

To request Medivitan Iv Ampullen, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, cold‑chain shipping details and any required import documentation.

Medivitan combines three B‑vitamins—B12, folic acid and B6—in a single ampoule, offering a broad‑spectrum approach to deficiency correction. Some alternatives provide only one or two of these vitamins, requiring multiple products. The combined formulation can simplify dosing and reduce the number of injections needed for comprehensive B‑vitamin repletion.

Medivitan Iv Ampullen should be stored at 2‑8 °C (refrigerated). Keep the ampoules in their original packaging, protect them from light, and avoid freezing or shaking the container. Proper cold‑chain storage preserves the stability and potency of the injectable vitamins.

The product is supplied as a sterile ampoule for intramuscular injection. A qualified healthcare professional draws the required volume into a sterile syringe and injects it into a suitable muscle site, typically the deltoid or gluteal muscle, following aseptic technique.

Serious adverse reactions, although rare, include anaphylaxis, severe hypersensitivity, Stevens‑Johnson syndrome, hemolytic anemia and thrombocytopenia. Patients should be observed after injection for any signs of allergic response, and immediate medical attention should be sought if severe symptoms develop.

Medivitan Iv Ampullen should not be used in individuals with known hypersensitivity to cyanocobalamin, folic acid, pyridoxine hydrochloride or any excipients in the formulation. It is also contraindicated in patients who have experienced severe allergic reactions to previous B‑vitamin injections.